Clinical features, risk factors, and outcomes of patients with interstitial pneumonia with autoimmune features: A population-based study
Comparison of magnetic resonance angiography and 18F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis
Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: A national estimate
Researchers develop online portal that aims to accelerate discoveries in precision cancer medicine
3 reasons to join M3 India Market Research Panel
- Contribute to improvements in Healthcare by sharing your insights
- Earn rewards in your free time
- Secure: We never share your personal information without your permission
Over 4 million Doctors across 9 countries
trust M3 Group for their daily practice.
M3 India is a Joint Venture between M3 Inc. Japan and Health Care at Home India Pvt. Ltd.
By leveraging internet based technologies, this initiative will expand access to information and enhance communication in the Indian healthcare sector.